English
한국어
Log in
or
Register
|
My account
|
Wishlist
(0)
|
My Cart (0)
You have no items in your shopping cart.
Home
Products
OPV /SPC /OEC /OTFT /DSSC
Organic Boronic Acids & Esters
MOFs and COFs
Impurities
Anthracene Compounds
Fluorene Compounds
Carbazole Compounds
Organophosphorus Compounds
Naphthalene Compounds
Heterocyclic Compounds
Thiophene
Azetidines
Indoles
Imidazoles
Morpholines
Oxetanes
Piperazines
Pyridazines
Pyridines
Pyrrolidines
Liquid Crystal Materials
Other OLED Intermediates
Other Building Blocks
About us
Custom Synthesis
Customer Support
Contact Us
Advanced Search
Home
Heterocyclic Compounds
Methyl 5-aminobenzo[b]thiophene-2-carboxylate
Methyl 5-aminobenzo[b]thiophene-2-carboxylate
Current rating is 0.00. Total votes 0.
CAS NO.:
20699-85-8
Catalog:
THI252
Formula:
C
10
H
9
NO
2
S
Purity:
98.00% +
Molecular Weight:
207.25
Pubchem CID:
2824064
InChI Key:
SIMBULBEQVHFPK-UHFFFAOYSA-N
Canonical SMILES:
COC(=O)C1=CC2=C(S1)C=CC(=C2)N
Storage:
Store in a cool, dry and well-ventilated area away from incompatible substances.
USD $
0.00
US Dollar
British Pound
Euro
Canadian Dollar
Australian Dollar
Russian Rouble
Japanese Yen
*
Size
[Please select Size]
1g [+$114.45]
5g [+$385.28]
10g [+$690.79]
Bulk Order
Quantity:
Enter quantity
The value must be from 1 to 9999
Inquiry
Buyer Protection
Full Refund
if you don't receive your order
Full or Partial Refund
, if the product doesn't comply with COA
Downloads
MSDS
For inquires including COA,NMR and MSDS,please send mail to
inquiry@acrospharmatech.com
Related products
3-(1,3-Dioxoisoindolin-2-yl)propanal
USD $0.00
Isonicotinic acid hydrazide
USD $0.00
2-(1,3-Dioxoisoindolin-2-yl)ethanesulfonylchloride
USD $0.00
2-Chloro-5-hydroxyisonicotinic acid
USD $0.00
2-Oxoindoline-6-carboxylic acid
USD $0.00
5-Amino-2-bromoisonicotinic acid
USD $0.00
Properties Information
Melting point:
178-179 ºC
Boiling point:
382.8±22.0 °C(Predicted)
Density
1.352±0.06 g/cm3(Predicted)
pka
3.52±0.10(Predicted)
Safety Information
Hazard Codes
Xn
Risk Statements
20/21/22-36/37/38
Safety Statements
22-26-36/37/39